Unilever’s £50bn offer for the consumer healthcare arm of GlaxoSmithKline (GSK) has been rejected – but this feels like the start of what could turn out to be a protracted takeover battle.
Source: Sky Business News
Unilever’s £50bn offer for the consumer healthcare arm of GlaxoSmithKline (GSK) has been rejected – but this feels like the start of what could turn out to be a protracted takeover battle.
Source: Sky Business News